Valproic acid vs. Onfi: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Valproic acid and Onfi. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 70,213 people who take Valproic acid and Onfi, and is updated regularly.
What is Valproic acid?
Valproic acid has active ingredients of valproic acid. It is often used in epilepsy. eHealthMe is studying from 36,193 Valproic acid users. Check the latest studies of Valproic acid.
What is Onfi?
Onfi has active ingredients of clobazam. It is often used in epilepsy. eHealthMe is studying from 7,809 Onfi users. Check the latest studies of Onfi.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
70,213 people who take Valproic acid and Onfi are studied.

Drugs being compared in this study:
- Onfi (clobazam)
- Valproic Acid (valproic acid)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Valproic Acid:
- not at all: 5.54 %
- somewhat: 22.48 %
- moderate: 28.66 %
- high: 26.38 %
- very high: 16.94 %
Onfi:
- not at all: 2.42 %
- somewhat: 20.16 %
- moderate: 39.52 %
- high: 20.97 %
- very high: 16.94 %
Want to compare Valproic acid with Onfi?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Gupta E, Kunjal R, Cury JD, "Severe hyponatremia due to valproic acid toxicity", Journal of clinical medicine research, 2015 Jan .
- Hwabejire JO, Lu J, Liu B, Li Y, Halaweish I, Alam HB, "Valproic acid for the treatment of hemorrhagic shock: a dose-optimization study", journal of surgical research, 2014 Jan .
- Gupta E, Kunjal R, Cury JD, "Severe hyponatremia due to valproic acid toxicity", Journal of clinical medicine research, 2015 Jan .
- Hwabejire JO, Lu J, Liu B, Li Y, Halaweish I, Alam HB, "Valproic acid for the treatment of hemorrhagic shock: a dose-optimization study", journal of surgical research, 2014 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Valproic acid (35,839 reports)
- Onfi (7,700 reports)
Browse all side effects of Valproic acid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Onfi:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on valproic acid and clobazam (the active ingredients of Valproic acid and Onfi, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Harvoni and Itching for Men aged 50-59 - 4 seconds ago
- Harvoni and Pruritus for Men aged 50-59 - 4 seconds ago
- Harvoni and Itchiness for Men aged 50-59 - 4 seconds ago
- Could Vancomycin cause Antimicrobial Susceptibility Test Resistant? - 5 seconds ago
- Antivert and Plasmacytoma Of Bone for Men aged 60+ - 12 seconds ago
- Antivert and Plasma Cell Myeloma for Men aged 60+ - 13 seconds ago
- Antivert and Plasma Cell Dyscrasia for Men aged 60+ - 13 seconds ago
- Antivert and Myeloma - Multiple for Men aged 60+ - 13 seconds ago
- Antivert and Malignant Plasmacytoma for Men aged 60+ - 13 seconds ago
- Antivert and Multiple Myeloma for Men aged 60+ - 14 seconds ago